Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck
Mohan Suntharalingam(University of Maryland, Baltimore), Barbara A. Conley(National Cancer Institute), Maria Jacobs(University of Maryland Medical System), Michael L. Haas(University of Maryland Medical System), David A. Van Echo(University of Maryland Medical System), Robert A. Ord(University of Maryland, Baltimore), Sharon Levy(University of Maryland, Baltimore), William C. Gray(University of Maryland Medical System), Robert I. Haddad(Georgetown University)
Cited by 50
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Recent Advances in Head and Neck Cancer
|New England Journal of Medicine|2008|926